NOTICE: Thank you for visiting our site. Your experience is important to us. We're upgrading our system to better serve you. During this time, purchases and member logins will be unavailable. Full functionality will be restored by Monday, 29 July.
Geoffrey K. Wu, PhD
FDA/CDER/OPQ/OLDP
Deputy Director, Office of Lifecycle Drug Products (OLDP)
Lieutenant Geoffrey Wu, PhD, CPH, is a scientist officer in the United States Public Health Service. He is currently the acting Associate Director for Science and Communication in the Office of Lifecycle Drug Products (OLDP), Office of Pharmaceutical Quality (OPQ), CDER. He is also a member on the OPQ Emerging Technology Team (ETT). Geoff has been deeply involved in, leading or co-leading regulatory review and research in the areas of supplemental NDAs, controlled correspondences for generic drugs, ANDAs, and supplemental ANDAs in the past six years.<br><br>
Geoff has training and education in pharmacy, pharmaceutical sciences, protein chemistry, polymer chemistry, and process analytical technology. He received his Ph.D. degree in Pharmaceutics and Pharmaceutical Chemistry from University of Utah, and B.S. in pharmacy and M.S. in pharmaceutics for Peking University, China. He has more than 20 publications and one patent in the above mentioned scientific and regulatory topics.
Geoff has training and education in pharmacy, pharmaceutical sciences, protein chemistry, polymer chemistry, and process analytical technology. He received his Ph.D. degree in Pharmaceutics and Pharmaceutical Chemistry from University of Utah, and B.S. in pharmacy and M.S. in pharmaceutics for Peking University, China. He has more than 20 publications and one patent in the above mentioned scientific and regulatory topics.